Selected Viral Research Publications

1. DiMaio, T. A., Gutierrez, K. D. & Lagunoff, M. Kaposi’s Sarcoma Herpesvirus downregulates Transforming Growth Factor-β2 to promote the enhanced stability of capillary-like tube formation. J. Virol. (2014). doi:10.1128/JVI.01696-14

2. Tulloch, F. et al. FMDV replicons encoding green fluorescent protein are replication competent. J. Virol. Methods 209C, 35–40 (2014).

3. Forrest, S. et al. Inhibition of the FMDV sub-genomic replicon by RNA aptamers. J. Gen. Virol. (2014). doi:10.1099/vir.0.067751-0

4. Lim, K. et al. Biophysical characterization of sites of host adaptive mutation in the influenza A virus RNA polymerase PB2 RNA-binding domain. Int. J. Biochem. Cell Biol. 53C, 237–245 (2014).

5. Beug, S. T. et al. Smac mimetics and innate immune stimuli synergize to promote tumor death. Nat. Biotechnol. (2014). doi:10.1038/nbt.2806

6. Alymova, I. V. et al. A Novel Cytotoxic Sequence Contributes to Influenza A Viral Protein PB1-F2 Pathogenicity and Predisposition to Secondary Bacterial Infection. J. Virol. 88, 503–15 (2014).

7. Omoto, S. & Mocarski, E. S. Transcription of True Late (γ2) Cytomegalovirus Genes Requires UL92 Function That Is Conserved among Beta- and Gammaherpesviruses. J. Virol. 88, 120–30 (2014).

8. Omoto, S. & Mocarski, E. S. Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J. Virol. 87, 8651–64 (2013).

9. McCormick, a L., Roback, L., Wynn, G. & Mocarski, E. S. Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology 435, 250–7 (2013).

10. Beran, R. K. F. et al. Cellular growth kinetics distinguish a cyclophilin inhibitor from an HSP90 inhibitor as a selective inhibitor of hepatitis C virus. PLoS One 7, e30286 (2012).

11. Gasperini, P. et al. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res. 72, 1157–69 (2012).